Cigna Group · 2026-08-05 · Importance 31 · Surprise 42
Third-party reporting says Cigna is conducting an ongoing review of its business portfolio. The review is discussed alongside uncertainty over the company’s pharmacy benefit management operations and regulatory pressure in the United States. The reports provide no transaction announcement, timeline, or quantified financial effect from potential portfolio changes.
Key facts
David Cordani's strategic maneuvers included the acquisition of Express Scripts. source
Under David Cordani's tenure Cigna was transformed into a $275 billion healthcare giant. source
David Cordani served a 17-year tenure as Cigna CEO. source